Amelioration of β-amyloid-induced cognitive dysfunction and hippocampal axon degeneration by curcumin is associated with suppression of CRMP-2 hyperphosphorylation

Neuroscience Letters

Volumn 557, Issue PB, 2013, Pages 112-117

  Wang, Yunliang ^a   Yin, Honglei ^b   Li, Jinfeng ^b   Zhang, Yuzhen ^b   Han, Bing ^b   Zeng, Zhilei ^a   Qiao, Nana ^b   Cui, Xiaomei ^b   Lou, Jiyu ^a   Li, Jing ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b No 148 Hospital of PLA   (China)

Author keywords

Alzheimer's disease; Amyloid protein; Axon; CRMP 2; Curcumin

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CURCUMIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; NERVE FIBER DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RAT; SPATIAL LEARNING; WESTERN BLOTTING;

ALZHEIMER'S DISEASE; AMYLOID Β PROTEIN; AXON; CRMP-2; CURCUMIN;

AMYLOID BETA-PEPTIDES; ANIMALS; AXONS; BLOTTING, WESTERN; CURCUMIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84888041977     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.10.024     Document Type: Article

References (23)

1. Arimura N., Menager C., Kawano Y., Yoshimura T., Kawabata S., Hattori A., Fukata Y., Amano M., Goshima Y., Inagaki M., Morone N., Usukura J., Kaibuchi K. Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Molecular and Cellular Biology 2005, 25:9973-9984.
2. Chae Y.C., Lee S., Heo K., Ha S.H., Jung Y., Kim J.H., Ihara Y., Suh P.G., Ryu S.H. Collapsin response mediator protein-2 regulates neurite formation by modulating tubulin GTPase activity. Cellular Signalling 2009, 21:1818-1826.
3. Chung M.A., Lee J.E., Lee J.Y., Ko M.J., Lee S.T., Kim H.J. Alteration of collapsin response mediator protein-2 expression in focal ischemic rat brain. Neuroreport 2005, 16:1647-1653.
4. Cole A.R., Noble W., van Aalten L., Plattner F., Meimaridou R., Hogan D., Taylor M., LaFrancois J., Gunn-Moore F., Verkhratsky A., Oddo S., LaFerla F., Giese K.P., Dineley K.T., Duff K., Richardson J.C., Yan S.D., Hanger D.P., Allan S.M., Sutherland C. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. Journal of Neurochemistry 2007, 103:1132-1144.
5. Cole G.M., Morihara T., Lim G.P., Yang F., Begum A., Frautschy S.A. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models. Annals of the New York Academy of Sciences 2004, 1035:68-84.
6. Cole G.M., Teter B., Frautschy S.A. Neuroprotective effects of curcumin. Advances in Experimental Medicine and Biology 2007, 595:197-212.
7. Fukata Y., Itoh T.J., Kimura T., Menager C., Nishimura T., Shiromizu T., Watanabe H., Inagaki N., Iwamatsu A., Hotani H., Kaibuchi K. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nature Cell Biology 2002, 4:583-591.
8. Garcia-Nino W.R., Tapia E., Zazueta C., Zatarain-Barron Z.L., Hernandez-Pando R., Vega-Garcia C.C., Pedraza-Chaverri J. Curcumin pretreatment prevents potassium dichromate-induced hepatotoxicity, oxidative stress, decreased respiratory complex I activity, and membrane permeability transition pore opening. Evidence-Based Complementary and Alternative Medicine: eCAM 2013, 2013:424692.
9. Gu Y., Hamajima N., Ihara Y. Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522. Biochemistry 2000, 39:4267-4275.
10. Guo L., Xing Y., Pan R., Jiang M., Gong Z., Lin L., Wang J., Xiong G., Dong J. Curcumin protects microglia and primary rat cortical neurons against HIV-1 gp120-mediated inflammation and apoptosis. PLoS ONE 2013, 8:e70565.
11. Joe B., Vijaykumar M., Lokesh B.R. Biological properties of curcumin-cellular and molecular mechanisms of action. Critical Reviews in Food Science and Nutrition 2004, 44:97-111.
12. Jorm A.F., Jolley D. The incidence of dementia: a meta-analysis. Neurology 1998, 51:728-733.
13. Lee C.Y., Jaw T., Tseng H.C., Chen I.C., Liou H.H. Lovastatin modulates glycogen synthase kinase-3beta pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus. PLoS ONE 2012, 7:e38789.
14. Mishra S., Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Annals of Indian Academy of Neurology 2008, 11:13-19.
15. Nakamura S., Murayama N., Noshita T., Annoura H., Ohno T. Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Research 2001, 912:128-136.
16. Nazari Q.A., Kume T., Izuo N., Takada-Takatori Y., Imaizumi A., Hashimoto T., Izumi Y., Akaike A. Neuroprotective effects of curcumin and highly bioavailable curcumin on oxidative stress induced by sodium nitroprusside in rat striatal cell culture. Biological & Pharmaceutical Bulletin 2013, 36:1356-1362.
17. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinate 1998, 80-89. Academic Press. fourth ed.
18. Thiyagarajan M., Sharma S.S. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sciences 2004, 74:969-985.
19. Veyrac A., Giannetti N., Charrier E., Reymond-Marron I., Aguera M., Rogemond V., Honnorat J., Jourdan F. Expression of collapsin response mediator proteins 1, 2 and 5 is differentially regulated in newly generated and mature neurons of the adult olfactory system. European Journal of Neuroscience 2005, 21:2635-2648.
20. Wang T., Wu X., Yin C., Klebe D., Zhang J.H., Qin X. CRMP-2 is involved in axon growth inhibition induced by RGMa in vitro and in vivo. Molecular Neurobiology 2013, 47:903-913.
21. Williamson R., van Aalten L., Mann D.M., Platt B., Plattner F., Bedford L., Mayer J., Howlett D., Usardi A., Sutherland C., Cole A.R. CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases. Journal of Alzheimer's Disease: JAD 2011, 27:615-625.
22. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry 2005, 280:5892-5901.
23. Zhou Y., Su Y., Li B., Liu F., Ryder J.W., Wu X., Gonzalez-DeWhitt P.A., Gelfanova V., Hale J.E., May P.C., Paul S.M., Ni B. Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science 2003, 302:1215-1217.